Quantification and Spectral Interference Studies of Selected Weak Chromophore Molecules Using ATR-FTIR Spectroscopy with Regression Tools

ABSTRACT

Background: Weak chromophore molecules present challenges in analytical method development for routine quality control testing. This study focuses on three such molecules: favipiravir and molnupiravir, antiviral drugs repurposed for COVID-19 treatment, and etidronate disodium, used for osteoporosis and multiple myeloma. Existing analytical methods face limitations due to their non-chromophore structures. Objectives: To address this, we developed three non-destructive ATR-FTIR (Attenuated Total Reflectance Fourier Transform Infrared) spectroscopic methods for purity assessment. Materials and Methods: Infrared spectra were scanned in the full IR region (4000-667 cm⁻¹), with calibration curves generated via TQ Analyst Pro software using partial least squares regression. The fingerprint regions (1393-1062 cm⁻¹) for favipiravir; Near-IR regions (1700-667 cm⁻¹) for molnupiravir and etidronate disodium) demonstrated excellent linearity (r² ≈ 0.9998-1.000). Results: The residual mean standard errors of calibration was <0.0025 for three active molecules, and intra-day/inter-day precision had relative standard deviations less than 5% after validation as per ICH guidelines. Conclusion: Interference studies confirmed that no spectral overlaps with inactive ingredients after comparing both placebos with and without all three above drugs, allowing potential application of this method for routine analysis of the formulation. These methods offer a sensitive, specific, and accurate and alternative method for quantitative analysis of weak chromophore molecules.

KEYWORDS

• Attenuated total reflectance infrared spectroscopy
• Etidronate
• Favipiravir
• Molnupiravir
• Quantification
• Validation

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20262387Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 60, ISSUE 3SDevelopment and evaluation of Dry Powder Inhalation Formulation of Remdesivir Nanosuspension by Spray Drying TechniqueArshad Shaikh, Mukesh Pandurang Ratnaparkhi, Sayali Vilas Jadhav, Shailendra Salvankar · pp. s1–s9Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3SOptimized Green Synthesis Approaches of Phenytoin Using Divalent Sulfate Salts and Chromatographic Purity Assessment via A Novel RP-HPLC MethodArka Chakraborty, Rajarshi Nath, Biplab Debnath, Arijit Das, Anindya Bose, Shambo Panda · pp. s1–s8Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3SFormulation and Evaluation of Beclomethasone Dipropionate Loaded Niosomal Gel for Topical UseMahesh Birajdar, Rohit Sarda, Shradha Tiwari, Dnyaneshwari Jadhav, Sameep Sonvane, Prakash Shivnechari, Kranti Satpute · pp. s918–s928Original ArticleSame type: Article
• Article · VOLUME 60, ISSUE 3SDesign and Development of Self-Micro Emulsifying Drug Delivery Systems of Rifaximin Using 32 Factorial DesignOnkar Vilas Jadhav, Twarita Dilip Deshpande, Udaykumar Baburao Bolmal, Anuj Jagannath Shinde, Shital Vishwas Patil · pp. s929–s943Original ArticleSame type: Article